Cargando…

Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients

BACKGROUND: Cancer-associated fibroblasts (CAFs) play multiple roles in regulating tumor metastasis and treatment response. Current clinical indicators are insufficient to accurately assess disease risk and radiotherapy response, emphasizing the urgent need for additional molecular prognostic marker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ran, Liu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533530/ https://www.ncbi.nlm.nih.gov/pubmed/36195908 http://dx.doi.org/10.1186/s12967-022-03656-5

Ejemplares similares

Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
por: Choe, Kevin S., et al.
Publicado: (2010)

Survival Disparities in the Radiotherapeutic Management of Lung Cancer by Regional Poverty Level
por: Mahase, Sean, et al.
Publicado: (2018)

Radiotherapeutic Management of Synchronous Prostate and Rectal Cancers Using Proton Beam Therapy
por: Chiang, Jennifer S., et al.
Publicado: (2021)

Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma
por: Pan, Zi-Qi, et al.
Publicado: (2020)

Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011)

Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Machine Learning-Based Radiomics Predicts Radiotherapeutic Response in Patients With Acromegaly
por: Fan, Yanghua, et al.
Publicado: (2019)

Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
por: Im, Jung Ho, et al.
Publicado: (2015)

Monitoring Radiotherapeutic Response in Prostate Cancer Patients Using High Throughput FTIR Spectroscopy of Liquid Biopsies
por: Medipally, Dinesh K.R., et al.
Publicado: (2019)

Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012)

Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer
por: Rastogi, Madhup, et al.
Publicado: (2013)

Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma
por: Zhang, Yong, et al.
Publicado: (2023)

Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect
por: Jing, Di, et al.
Publicado: (2022)

Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
por: Herrera, Mercedes, et al.
Publicado: (2021)

[(177)Lu]Lu-PSMA-617 (Pluvicto(TM)): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2022)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)

Case series illustrating the synergistic use of hydrogel spacer and MR-guidance to increase the radiotherapeutic index for localized prostate cancer
por: Sanmamed, Noelia, et al.
Publicado: (2019)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
por: Chen, Lei, et al.
Publicado: (2022)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas
por: Combs, Stephanie E, et al.
Publicado: (2007)

Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
por: Lee, Sungmin, et al.
Publicado: (2018)

(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer
por: A, Jun, et al.
Publicado: (2021)

Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

Cost Analysis of Selected Radiotherapeutic Modalities for Prostate Cancer Treatment—Czech Republic Case Study for the Purposes of Hospital Based HTA
por: Hospodková, Petra, et al.
Publicado: (2021)

Radiotherapeutic treatment options for oligotopic malignant liver lesions
por: Wust, Peter, et al.
Publicado: (2021)

Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
por: Deng, Guodong, et al.
Publicado: (2017)

LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer
por: Wang, You-hong, et al.
Publicado: (2021)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non‐small cell lung cancer patients with brain metastasis
por: Peng, Ling, et al.
Publicado: (2023)

Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
por: Dreher, Constantin, et al.
Publicado: (2017)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases
por: Tsao, May N, et al.
Publicado: (2005)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
por: Wüstemann, Till, et al.
Publicado: (2016)

Radiotherapeutic management of brain tumours during the COVID-19 pandemic
por: Balakrishnan, Rajesh, et al.
Publicado: (2020)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer
por: Zhou, Zhiyang, et al.
Publicado: (2023)

Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells
por: Hintelmann, Katharina, et al.
Publicado: (2022)

Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts
por: Jones, Michelle L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l8tfenj0lmaj9tk6t7j0q0np48